Evidence map›Paper›PMID 31509298›Full record

ArticleJournal of leukocyte biology2019

Syk-dependent glycolytic reprogramming in dendritic cells regulates IL-1β production to β-glucan ligands in a TLR-independent manner.

Phyu M Thwe, Daniel I Fritz, Julia P Snyder, Portia R Smith, Kylie D Curtis, Alexandra O'Donnell, Nicholas A Galasso, Leslie A Sepaniac, Benjamin J Adamik, Laura R Hoyt and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Biological Effects of β-Glucans on Osteoclastogenesis.Molecules (Basel, Switzerland) · 2021
    Review
  15. Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders.International journal of environmental research and public health · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Phyu M ThweCellular, Molecular, and Biomedical (CMB) Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA.
Daniel I FritzUniversity of Vermont, Burlington, Vermont, USA.
Julia P SnyderCellular, Molecular, and Biomedical (CMB) Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA.
Portia R SmithUniversity of Vermont, Burlington, Vermont, USA.
Kylie D CurtisUniversity of Vermont, Burlington, Vermont, USA.
Alexandra O'DonnellUniversity of Vermont, Burlington, Vermont, USA.
Nicholas A GalassoUniversity of Vermont, Burlington, Vermont, USA.
Leslie A SepaniacCellular, Molecular, and Biomedical (CMB) Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA.
Benjamin J AdamikUniversity of Vermont, Burlington, Vermont, USA.
Laura R HoytUniversity of Vermont, Burlington, Vermont, USA.
Princess D RodriguezCellular, Molecular, and Biomedical (CMB) Sciences Graduate Program, University of Vermont, Burlington, Vermont, USA.
Tyler C HoganUniversity of Vermont, Burlington, Vermont, USA.
Andrea F SchmidtUniversity of Vermont, Burlington, Vermont, USA.
Matthew E PoynterVermont Lung Center, Division of Pulmonary Disease and Critical Care, Department of Medicine, University of Vermont, Burlington, Vermont, USA.
Eyal AmielDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, Vermont, USA.ORCID 0000-0002-1578-8705
University of Vermont · US

Funding

Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Obese Allergic Asthma and the Impact of Weight Loss on Airway Epithelial FunctionR01HL133920 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DIXON, ANNE E, POYNTER, MATTHEW E · 2016 to 2020
$3.9M
Vermont Immunology/Infectious Diseases Training GrantT32AI055402 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GARY E WARD · 2005 to 2026
$2.7M
Ketone Body Supplementation in Obese AsthmaR01HL142081 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI POYNTER, MATTHEW E · 2018 to 2021
$1.8M
The Role of Glycogen Metabolism in Supporting Dendritic Cell Immune FunctionR21AI135385 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI AMIEL, EYAL · 2018 to 2019
$422k
NHLBI NIH HHS R01 HL133920NHLBI NIH HHS R01 HL142081NIAID NIH HHS R21 AI135385NIAID NIH HHS T32 AI055402NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Dendritic cells (DCs) activated via TLR ligation experience metabolic reprogramming, in which the cells are heavily dependent on glucose and glycolysis for the synthesis of molecular building blocks essential for maturation, cytokine production, and the ability to stimulate T cells. Although the TLR-driven metabolic reprogramming events are well documented, fungal-mediated metabolic regulation via C-type lectin receptors such as Dectin-1 and Dectin-2 is not clearly understood. Here, we show that activation of DCs with fungal-associated β-glucan ligands induces acute glycolytic reprogramming that supports the production of IL-1β and its secretion subsequent to NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome activation. This acute glycolytic induction in response to β-glucan ligands requires spleen tyrosine kinase signaling in a TLR-independent manner, suggesting now that different classes of innate immune receptors functionally induce conserved metabolic responses to support immune cell activation. These studies provide new insight into the complexities of metabolic regulation of DCs immune effector function regarding cellular activation associated with protection against fungal microbes.

Indexed as

Animalsbeta-GlucansDendritic CellsGlycolysisInterleukin-1betaLectins, C-TypeLigandsMiceMyeloid Differentiation Factor 88NLR Family, Pyrin Domain-Containing 3 ProteinPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionSyk KinaseToll-Like ReceptorsAkt1 protein, mousebeta-GlucansInterleukin-1betaLectins, C-TypeLigandsMyeloid Differentiation Factor 88NLR Family, Pyrin Domain-Containing 3 ProteinPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktSyk KinaseSyk protein, mouseTbk1 protein, mouseToll-Like Receptorsdectin-1/2dendritic cells (DCs)glycolysisinflammasomeNOD-, LRR- and pyrin domain-containing protein 3 (NLRP3)oxidative phosphorylation (OXPHOS)pattern recognition receptor (PRR)spleen tyrosine kinase (Syk)toll-like receptor (TLR)

Identifiers

PMID31509298
PMCPMC6883127
OpenAlexW2972971116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.